tma workstation manual tissue arrayer mta booster (Alphelys Inc)
90
Structured Review
Alphelys Inc
tma workstation manual tissue arrayer mta booster
Tma Workstation Manual Tissue Arrayer Mta Booster, supplied by Alphelys Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/manual+arrayer/tma+workstation+manual+tissue+arrayer+mta+booster/pm39796635-29-21-28
Average 90 stars, based on 1 article reviews
Tma Workstation Manual Tissue Arrayer Mta Booster, supplied by Alphelys Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/manual+arrayer/tma+workstation+manual+tissue+arrayer+mta+booster/pm39796635-29-21-28
Average 90 stars, based on 1 article reviews
tma workstation manual tissue arrayer mta booster - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Curcumin and NCLX inhibitors share anti-tumoral mechanisms in microsatellite-instability-driven colorectal cancer Article Snippet: For each case, nine cores of 0.6-mm diameter (three in the tumor center, three in the invasive front and three in non-tumor tissue) were transferred from the selected areas to the recipient block, using a Construct:Article Title: The prognostic significance of Nectin-2 and Nectin-4 expression in glial tumors. Article Snippet: Glial tumors are the most frequent neoplasms of the central nervous system in adults and despite recent advances in diagnosis and treatment of the disease, the prognosis of glioma is poor.. Therefore, there is a great need to identify new prognostic factors and potential immunotherapeutic targets.. Members of the Nectin family of proteins are gaining significant attention as possible diagnostic and immunotherapeutic targets in many solid tumors, but they have not been extensively investigated in glial tumors. Blocking Assay:Article Title: PD-L1 expression and its prognostic value in metastatic papillary renal cell carcinoma: Results from a GETUG multicenter retrospective cohort. Article Snippet: Introduction: Papillary renal cell carcinoma (pRCC) is a rare and aggressive cancer with no specifically established therapeutic strategy in the metastatic setting.. Combinations of tyrosine kinase and immune checkpoint inhibitors (ICI) are a promising option.. We aimed to study the immune landscape of metastatic pRCC, and its interactions with angiogenesis pathways, to search for potential therapeutic targets. Article Title: Pivotal role of the ORAI3-STIM2 complex in the control of mitotic death and prostate cancer cell cycle progression. Article Snippet: Prostate cancer (PCa) represents one of the most frequent diagnosed cancer in males worldwide.. Due to routine screening tests and the efficiency of available treatments, PCa-related deaths have significantly decreased over the past decades.. However, PCa remains a critical threat if detected at a late stage in which, cancer cells would have already detached from the primary tumor to spread and invade other parts of the body. Article Title: Spatial Genomics Identifies Heat Shock Proteins as Key Molecular Changes Associated to Adipose Periprostatic Space Invasion in Prostate Cancer. Article Snippet: .. For each localization, three cores of 0.6 mm diameter were transferred from the selected areas to the recipient block, using a Article Title: Endogenous ether-lipids differentially promote tumour aggressiveness by regulating the SK3 channel. Article Snippet: .. For each case, 3 cores 0.6 diameter were transferred from the selected areas to the recipient block, using a Article Title: Variable effects of periprostatic adipose tissue on prostate cancer cells: Role of adipose tissue lipid composition and cancer cells related factors. Article Snippet: Funding information region center val de loire Abstract Background: Periprostatic adipose tissue (PPAT) is likely to modulate prostate cancer (PCa) progression.. We analyzed the variations in the effect of PPAT on cancer cells, according to its fatty acid (FA) composition and tumor characteristics.. Methods: The expression of markers of aggressiveness Ki67 and Zeb1, and epigenetic marks that could be modified during PCa progression, was analyzed by immunohistochemistry on a tissue‐micro‐array containing 59 pT3 PCa, including intra‐prostatic areas and extra‐prostatic foci in contact with PPAT belonging to the same tumor. |